In agreement, the levels of p53 are negatively correlated with IDH1-R132H levels in human gliomas [30], supporting at clinical levels the molecular mechanism dependent on the 2-HG/HIF-2α/miR-380-5p axis described in vitro. The gene discussed is IDH1; the disease is glioma.